Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Oncolytics Biotech, Inc. (NQ: ONCY)
2.750 USD  +0.030 (+1.10%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 2.970
Bid (Size) 2.420 (100)
Ask (Size) 3.700 (1000)
Prev. Close 2.720
Today's Range 2.640 - 3.060
52wk Range 1.600 - 4.930
Shares Outstanding 84,758,818
Dividend Yield N/A
Top News
More News
ONC.CA Makes Bullish Cross Above Critical Moving Average
May 22, 2013
In trading on Wednesday, shares of Oncolytics Biotech Incorporated (ONC) crossed above their 200 day moving average of $2.94, changing hands as high as $3.15 per share. Oncolytics Biotech Incorporated... Read More
category Dividends
from Dividend Channel
Oncolytics cancer drug meets mid-stage trial goal, shares rise
May 22, 2013
May 22 (Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with... Read More
category companyNews
from Reuters: Company News

More News
Read More
StreetInsider.com Pre-Open Movers 5/22: (ZLC) (SKS) (TOL) Higher; (UAN) (TGT) (SODA) Lower (more...)
May 22, 2013
from StreetInsider.com News Articles
Oncolytics Announces First Stage of Metastatic Melanoma Phase 2 Trial Meets Primary Endpoint
May 22, 2013
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Oncolytics Biotech (ONCY) REOLYSIN w/ REO 020 Met Primary Endpoint in Phase 2
May 22, 2013
from StreetInsider.com News Articles
Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial
May 22, 2013
from PR Newswire
Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care Conference
May 14, 2013
from PR Newswire
Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of Shareholders
May 10, 2013
from PR Newswire
Oncolytics Biotech (ONCY) Posts Q1 Loss of 8c/Share
May 09, 2013
from StreetInsider.com News Articles
Oncolytics Biotech® Inc. Announces First Quarter 2013 Results
May 09, 2013
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here